Prognostic	O
impact	O
of	O
pathological	O
complete	O
remission	O
after	O
preoperative	O
irradiation	O
in	O
patients	O
with	O
locally	O
advanced	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
:	O
re	O
-	O
analysis	O
of	O
a	O
phase	B-study_type
3	I-study_type
clinical	I-study_type
study	I-study_type
Prognostic	O
impact	O
of	O
pathological	O
complete	O
remission	O
after	O
preoperative	O
irradiation	O
in	O
patients	O
with	O
locally	O
advanced	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
:	O
re	O
-	O
analysis	O
of	O
a	O
phase	B-study_type
3	I-study_type
clinical	I-study_type
study	I-study_type
05	O
Mar	O
,	O
2014	O
05	O
Mar	O
,	O
2014	O
KaiWang	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JunlinYi	B-authors
yijunlin1969@163.com	O

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
XiaodongHuang	O

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
YuanQu	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JingweiLuo	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JianpingXiao	B-authors
ShipingZhang	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
YuanTang	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
WeixinLiu	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
LiGao	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
ZhengangXu	B-authors

Prognostic	O
impact	O
of	O
pathological	O
complete	O
remission	O
after	O
preoperative	O
irradiation	O
in	O
patients	O
with	O
locally	O
advanced	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
:	O
re	O
-	O
analysis	O
of	O
a	O
phase	B-study_type
3	I-study_type
clinical	I-study_type
study	I-study_type

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JunlinYi	B-authors
yijunlin1969@163.com	O

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
XiaodongHuang	O

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
YuanQu	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JingweiLuo	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JianpingXiao	B-authors
ShipingZhang	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
YuanTang	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
WeixinLiu	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
LiGao	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
ZhengangXu	B-authors

Prognostic	O
impact	O
of	O
pathological	O
complete	O
remission	O
after	O
preoperative	O
irradiation	O
in	O
patients	O
with	O
locally	O
advanced	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
:	O
re	O
-	O
analysis	O
of	O
a	O
phase	B-study_type
3	I-study_type
clinical	I-study_type
study	I-study_type

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JunlinYi	B-authors
yijunlin1969@163.com	O

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
XiaodongHuang	O

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
YuanQu	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JingweiLuo	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
JianpingXiao	B-authors
ShipingZhang	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
YuanTang	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
WeixinLiu	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
LiGao	B-authors

Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O
China	O
ZhengangXu	B-authors

Prognostic	O
impact	O
of	O
pathological	O
complete	O
remission	O
after	O
preoperative	O
irradiation	O
in	O
patients	O
with	O
locally	O
advanced	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
:	O
re	O
-	O
analysis	O
of	O
a	O
phase	B-study_type
3	I-study_type
clinical	I-study_type
study	I-study_type
KaiWang	B-authors

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Department	O
of	O
Radiation	O
Oncology	O
,	O
National	O
Cancer	O
Center	O
/	O
Cancer	O
Hospital	O
,	O
Chinese	O
Academy	O
of	O
Medical	O
Sciences	O
and	O
Peking	O
Union	O
Medical	O
College	O
Beijing	O

China	O
Beijing	O
China	O
Prognostic	O
impact	O
of	O
pathological	O
complete	O
remission	O
after	O
preoperative	O
irradiation	O
in	O
patients	O
with	O
locally	O
advanced	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
:	O
re	O
-	O
analysis	O
of	O
a	O
phase	B-study_type
3	I-study_type
clinical	I-study_type
study	I-study_type
05	O
Mar	O
,	O
2014	O
05	O
Mar	O
,	O
2014	O
05	O
Mar	O
,	O
2014	O
10.1186	O
/	O
s13014	O
-	O
019	O
-	O
1428	O
-	O
4	O

Although	O
surgery	O
followed	O
by	O
radiotherapy	O
and/or	O
concurrent	O
chemoradio	O
-	O
therapy	O
has	O
been	O
the	O
major	O
treatment	O
choice	O
recommended	O
by	O
the	O
NCCN	O
guideline	O
for	O
treating	O
locally	O
advanced	O
head	O
and	O
neck	O
squamous	O
cell	O
carcinoma	O
(	O
HNSCC	O
)	O
for	O
many	O
years	O
[	O
1	O
]	O
,	O
the	O
outcome	O
with	O
this	O
regimen	O
is	O
still	O
limited	O
by	O
a	O
low	O
5-year	O
survival	O
rate	O
,	O
which	O
remains	O
<	O
40	O
%	O
[	O
2,3	O
]	O
.	O
In	O
recent	O
years	O
,	O
several	O
researches	O
have	O
suggested	O
that	O
preoperative	O
radiotherapy	O
and	O
preoperative	O
concurrent	O
chemoradiotherapy	O
may	O
improve	O
the	O
overall	O
survival	O
(	O
OS	O
)	O
compared	O
to	O
surgery	O
alone	O
in	O
patients	O
with	O
head	O
and	O
neck	O
cancer	O
[	O
4][5][6	O
]	O
.	O
The	O
advantages	O
of	O
preoperative	O
radiotherapy	O
or	O
preoperative	O
concurrent	O
chemoradiotherapy	O
for	O
head	O
and	O
neck	O
cancer	O
include	O
down	O
-	O
staging	O
,	O
increased	O
resectability	O
rate	O
,	O
etc	O
.	O
Further	O
evidence	O
from	O
several	O
phase	O
2	O
studies	O
have	O
shown	O
that	O
preoperative	O
concurrent	O
chemoradiotherapy	O
provides	O
excellent	O
treatment	O
outcomes	O
by	O
leading	O
to	O
a	O
pathological	O
complete	O
response	O
rate	O
ranging	O
from	O
35	O
to	O
61	O
%	O
and	O
an	O
increased	O
5-year	O
OS	O
rate	O
of	O
up	O
to	O
70	O
-	O
81.5	O
%	O
[	O
5][6][7][8	O
]	O
.	O

Several	O
authors	O
have	O
suggested	O
that	O
the	O
pathological	O
response	O
to	O
preoperative	O
radiotherapy	O
or	O
chemoradiotherapy	O
is	O
a	O
valuable	O
prognostic	O
factor	O
for	O
local	O
control	O
and	O
OS	O
[	O
9,10	O
]	O
.	O
In	O
one	O
of	O
our	O
randomized	B-study_type
phase	I-study_type
3	I-study_type
studies	I-study_type
,	O
we	O
evaluated	O
the	O
role	O
of	O
adding	O
concurrent	B-arm_description
cisplatin	I-arm_description
to	I-arm_description
preoperative	B-arm_description
radiotherapy	I-arm_description
in	O
the	O
treatment	O
of	O
locally	O
advanced	O
HNSCC	O
[	O
11	O
]	O
.	O
In	O
this	O
study	O
,	O
222	O
eligible	O
patients	O
were	O
randomly	O
assigned	O
to	O
a	O
preoperative	B-arm_description
radiotherapy	I-arm_description
group	I-arm_description
(	O
n	O
=	O
118	O
)	O
or	O
a	O
preoperative	B-arm_description
concurrent	I-arm_description
chemoradiotherapy	I-arm_description
group	I-arm_description
(	O
n	O
=	O
104	O
)	O
.	O
The	O
results	O
revealed	O
that	O
preoperative	B-arm_description
concurrent	I-arm_description
chemoradiotherapy	I-arm_description
led	O
to	O
a	O
significantly	O
improved	O
distant	O
metastasis	O
-	O
free	O
survival	O
(	O
DMFS	O
)	O
compared	O
to	O
preoperative	B-arm_description
radiotherapy	I-arm_description
alone	I-arm_description
.	O
According	O
to	O
the	O
protocol	O
,	O
non	O
-	O
responders	O
(	O
defined	O
by	O
<	O
80	O
%	O
reduction	O
of	O
the	O
primary	O
lesion	O
after	O
preoperative	O
treatment	O
)	O
,	O
subsequently	O
underwent	O
resection	O
of	O
the	O
primary	O
lesion	O
with	O
or	O
without	O
neck	O
dissection	O
depending	O
on	O
the	O
nodal	O
status	O
.	O
In	O
total	O
,	O
72	O
non	O
-	O
responders	O
(	O
33.8	O
%	O
)	O
were	O
observed	O
in	O
this	O
phase	B-study_type
3	I-study_type
study	I-study_type
.	O

In	O
the	O
present	O
study	O
,	O
we	O
analyzed	O
the	O
relationships	O
between	O
pathological	O
complete	O
remission	O
(	O
pCR	O
)	O
and	O
clinical	O
outcomes	O
in	O
these	O
72	O
non	O
-	O
responder	O
patients	O
.	O

The	O
details	O
of	O
the	O
study	O
design	O
and	O
data	O
collection	O
have	O
been	O
published	O
in	O
our	O
previous	O
study	O
[	O
11	O
]	O
.	O
In	O
brief	O
,	O
from	O
September	O
2002	O
to	O
May	O
2012	O
,	O
a	O
total	O
of	O
222	O
HNSCC	O
patients	O
were	O
enrolled	O
in	O
this	O
phase	B-study_type
3	I-study_type
study	I-study_type
,	O
among	O
which	O
104	O
patients	O
were	O
assigned	O
to	O
the	O
preoperative	B-arm_description
concurrent	I-arm_description
chemoradiotherapy	I-arm_description
group	I-arm_description
and	O
118	O
patients	O
were	O
assigned	O
to	O
the	O
preoperative	B-arm_description
radiotherapy	I-arm_description
group	I-arm_description
.	O

All	O
these	O
patients	O
received	O
radiotherapy	B-arm_description
with	O
either	O
twodimensional	B-arm_description
or	O
intensity	B-arm_description
-	I-arm_description
modulated	I-arm_description
radiotherapy	I-arm_description
(	O
IMRT	B-arm_description
)	O
.	O
Patients	O
assigned	O
to	O
the	O
chemoradiotherapy	O
group	O
additionally	O
received	O
concurrent	O
chemotherapy	O
with	O
30	B-arm_dosage
mg/	I-arm_dosage
m	I-arm_dosage
2	I-arm_dosage
cisplatin	O
weekly	B-arm_dosage
.	O
The	O
tumor	O
response	O
was	O
assessed	O
by	O
computed	O
tomography	O
(	O
CT	O
)	O
and/or	O
magnetic	O
resonance	O
imaging	O
(	O
MRI	O
)	O
and	O
endoscopy	O
examination	O
at	O
the	O
end	O
of	O
the	O
5th	O
week	O
(	O
50	O
Gy	O
)	O
.	O
Non	O
-	O
responders	O
(	O
defined	O
as	O
<	O
80	O
%	O
reduction	O
of	O
the	O
primary	O
lesion	O
volume	O
)	O
underwent	O
resection	O
of	O
the	O
primary	O
tumor	O
and	O
modified	O
neck	O
dissection	O
within	O
4	O
-	O
6	O
weeks	O
after	O
the	O
completion	O
of	O
preoperative	O
treatment	O
.	O
Seventy	O
-	O
two	O
patients	O
were	O
non	O
-	O
responders	O
,	O
including	O
35	O
patients	O
in	O
the	O
preoperative	B-arm_description
radiotherapy	I-arm_description
group	O
and	O
37	O
patients	O
in	O
the	O
chemoradiotherapy	B-arm_description
group	I-arm_description
.	O

The	O
surgical	O
samples	O
of	O
all	O
clinical	O
non	O
-	O
responders	O
were	O
assessed	O
pathologically	O
,	O
and	O
patients	O
were	O
classified	O
according	O
to	O
the	O
pathological	O
response	O
as	O
the	O
pCR	O
group	O
and	O
non	O
-	O
pCR	O
group	O
,	O
depending	O
on	O
whether	O
residual	O
tumor	O
cells	O
remained	O
in	O
the	O
surgical	O
sample	O
or	O
not	O
.	O

After	O
completion	O
of	O
the	O
treatment	O
plan	O
,	O
patients	O
were	O
followed	O
up	O
for	O
a	O
minimum	O
of	O
5	O
years	O
or	O
until	O
death	O
,	O
with	O
a	O
regular	O
frequency	O
:	O
at	O
1	O
month	O
,	O
every	O
3	O
months	O
for	O
the	O
first	O
2	O
years	O
,	O
every	O
6	O
months	O
for	O
the	O
2	O
-	O
5	O
years	O
after	O
treatment	O
,	O
and	O
every	O
year	O
thereafter	O
.	O

In	O
our	O
previous	O
study	O
,	O
we	O
revealed	O
that	O
in	O
a	O
subset	O
of	O
patients	O
with	O
primary	O
tumors	O
of	O
the	O
larynx	O
-	O
hypopharynx	O
,	O
preoperative	B-arm_description
chemoradiotherapy	I-arm_description
significantly	O
improved	O
the	O
PFS	B-arm_efficacy_metric
and	O
DMFS	O
,	O
and	O
also	O
provided	O
a	O
borderline	O
benefit	O
in	O
OS	O
in	O
compared	O
with	O
preoperative	O
radiotherapy	O
.	O
Therefore	O
,	O
in	O
the	O
current	O
study	O
,	O
a	O
sub	O
-	O
analysis	O
comparing	O
clinical	O
outcomes	O
in	O
patients	O
with	O
larynxhypopharynx	O
primary	O
tumors	O
was	O
performed	O
.	O

Log	O
-	O
rank	O
test	O
was	O
applied	O
to	O
compare	O
the	O
differences	O
in	O
baseline	O
characteristics	O
between	O
pCR	O
and	O
non	O
-	O
pCR	O
patients	O
.	O
The	O
LC	O
,	O
OS	O
,	O
PFS	B-arm_efficacy_metric
and	O
DMFS	O
were	O
calculated	O
by	O
the	O
Kaplan	O
-	O
Meier	O
method	O
.	O
The	O
multivariate	O
analysis	O
were	O
by	O
Cox	O
regressive	O
analysis	O
.	O
All	O
tests	O
were	O
two	O
-	O
sided	O
and	O
p	O
<	O
0.05	O
was	O
considered	O
statistically	O
significant	O
.	O
All	O
analyses	O
were	O
conducted	O
using	O
SPSS	O
21.0	O
software	O
(	O
IBM	O
Corporation	O
,	O
Armonk	O
,	O
New	O
York	O
,	O
U.S	O
)	O
.	O

The	O
total	O
of	O
72	O
non	B-arm_description
-	I-arm_description
responders	I-arm_description
included	O
37	O
patients	O
in	O
the	O
preoperative	B-arm_description
concurrent	I-arm_description
chemoradiotherapy	I-arm_description
group	I-arm_description
(	O
n	O
=	O
104	O
)	O
and	O
35	O
patients	O
in	O
the	O
preoperative	B-arm_description
radiotherapy	I-arm_description
group	I-arm_description
(	O
n	O
=	O
118	O
)	O
.	O
Among	O
these	O
72	O
non	O
-	O
responders	O
,	O
25	O
patients	O
(	O
34.7	O
%	O
)	O
achieved	O
pCR	O
,	O
including	O
10	O
patients	O
(	O
10/37	O
)	O
in	O
the	O
chemoradiotherapy	B-arm_description
group	I-arm_description
and	O
15	O
patients	O
(	O
15/25	O
)	O
in	O
the	O
radiotherapy	B-arm_description
group	I-arm_description
(	O
Table	O
1	O
)	O
.	O
There	O
were	O
no	O
significant	O
differences	O
between	O
the	O
pCR	O
and	O
non	O
-	O
pCR	O
groups	O
in	O
terms	O
of	O
primary	O
tumor	O
site	O
,	O
tumor	O
staging	O
(	O
T	O
,	O
N	O
stage	O
)	O
,	O
grades	O
of	O
clinical	O
group	O
,	O
and	O
treatment	O
technique	O
(	O
all	O
p	O
>	O
0.05	O
)	O
.	O

Over	O
a	O
median	O
follow	O
-	O
up	O
of	O
24	O
months	O
(	O
range	O
,	O
3	O
-	O
122	O
months	O
)	O
,	O
the	O
5-year	O
estimated	O
LC	O
,	O
OS	O
,	O
PFS	B-arm_efficacy_metric
,	O
and	O
DMFS	O
for	O
pCR	B-arm_description
patients	I-arm_description
and	O
non	B-arm_description
-	I-arm_description
pCR	I-arm_description
patients	I-arm_description
were	O
93.2	O
%	O
vs.	O
67.7	O
%	O
(	O
p	O
=	O
0.007	O
)	O
,	O
83.3	O
%	O
vs.	O
39.7	O
%	O
(	O
p	O
=	O
0.0006	O
)	O
,	O
76.1	B-arm_efficacy_results
%	I-arm_efficacy_results
vs.	O
44.0	B-arm_efficacy_results
%	I-arm_efficacy_results
(	I-arm_efficacy_results
p	I-arm_efficacy_results
=	I-arm_efficacy_results
0.003	I-arm_efficacy_results
)	I-arm_efficacy_results
,	O
and	O
90.4	O
%	O
vs.	O
56.3	O
%	O
(	O
p	O
=	O
0.005	O
)	O
,	O
respectively	O
(	O
Fig	O
.	O
1	O
)	O
.	O

There	O
were	O
46	O
non	B-arm_description
-	I-arm_description
responders	I-arm_description
with	O
larynxhypopharynx	O
primary	O
tumors	O
,	O
17	O
of	O
whom	O
achieved	O
pCR	O
of	O
the	O
primary	O
lesion	O
.	O
The	O
5-year	O
estimated	O
LC	O
,	O
OS	O
,	O
PFS	B-arm_efficacy_metric
,	O
and	O
DMFS	O
for	O
these	O
pCR	B-arm_description
and	O
non	B-arm_description
-	I-arm_description
pCR	I-arm_description
patients	O
were	O
100	O
%	O
vs.	O
81.4	O
%	O
(	O
p	O
=	O
0.068	O
)	O
,	O
94.7	O
%	O
vs.	O
50.1	O
%	O
(	O
p	O
=	O
0.008	O
)	O
,	O
81.9	B-arm_efficacy_results
%	I-arm_efficacy_results
vs.	O
51.2	B-arm_efficacy_results
%	I-arm_efficacy_results
(	I-arm_efficacy_results
p	I-arm_efficacy_results
=	I-arm_efficacy_results
0.03	I-arm_efficacy_results
)	I-arm_efficacy_results
,	O
and	O
94.1	O
%	O
vs.	O
61.1	O
%	O
(	O
p	O
=	O
0.02	O
)	O
,	O
respectively	O
(	O
Fig	O
.	O
2	O
)	O
.	O

In	O
multivariate	O
analysis	O
,	O
pCR	O
was	O
an	O
independent	O
prognostic	O
factors	O
of	O
LC(p	O
=	O
0.002	O
)	O
(	O
Table	O
2	O
)	O
and	O
OSwith	O
statistically	O
significant	O
differences	O
(	O
p<0.001	O
)	O
(	O
Table	O
3	O
)	O
.	O
And	O
pCR	O
also	O
played	O
an	O
significant	O
role	O
in	O
DMFS	O
and	O
PFS	B-arm_efficacy_metric
(	O
Additional	O
file	O
1	O
:	O
Table	O
S1	O
)	O
.	O
In	O
addition	O
,	O
the	O
degree	O
of	O
pathological	O
differentiation	O
,	O
primary	O
lesion	O
in	O
hypopharynx	O
/	O
larynx	O
and	O
N	O
stage	O
were	O
also	O
independent	O
prognostic	O
factors	O
for	O
OS	O
.	O
Other	O
factors	O
such	O
as	O
gender	O
,	O
age	O
,	O
T	O
stage	O
,	O
technology	O
of	O
radiation	O
and	O
chemotherapy	O
were	O
not	O
independent	O
prognostic	O
factors	O
for	O
OS	O
.	O